AU1885083A - Process for the preparation of 3-amino-5-hydroxybenzoic acidsand derivatives and analogues thereof - Google Patents
Process for the preparation of 3-amino-5-hydroxybenzoic acidsand derivatives and analogues thereofInfo
- Publication number
- AU1885083A AU1885083A AU18850/83A AU1885083A AU1885083A AU 1885083 A AU1885083 A AU 1885083A AU 18850/83 A AU18850/83 A AU 18850/83A AU 1885083 A AU1885083 A AU 1885083A AU 1885083 A AU1885083 A AU 1885083A
- Authority
- AU
- Australia
- Prior art keywords
- general formula
- acid
- amino
- hydroxybenzoic
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 22
- 230000008569 process Effects 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 7
- UYEMGAFJOZZIFP-UHFFFAOYSA-N 3,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC(O)=C1 UYEMGAFJOZZIFP-UHFFFAOYSA-N 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 150000002148 esters Chemical class 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- 230000007062 hydrolysis Effects 0.000 claims description 10
- 238000006460 hydrolysis reaction Methods 0.000 claims description 10
- 150000001408 amides Chemical class 0.000 claims description 9
- 230000032050 esterification Effects 0.000 claims description 9
- 238000005886 esterification reaction Methods 0.000 claims description 9
- KKEBXNMGHUCPEZ-UHFFFAOYSA-N 4-phenyl-1-(2-sulfanylethyl)imidazolidin-2-one Chemical compound N1C(=O)N(CCS)CC1C1=CC=CC=C1 KKEBXNMGHUCPEZ-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- IJFXRHURBJZNAO-UHFFFAOYSA-N 3-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1 IJFXRHURBJZNAO-UHFFFAOYSA-N 0.000 claims 1
- QPEJHSFTZVMSJH-UHFFFAOYSA-N 3-amino-5-hydroxybenzoic acid Chemical class NC1=CC(O)=CC(C(O)=O)=C1 QPEJHSFTZVMSJH-UHFFFAOYSA-N 0.000 description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 230000003115 biocidal effect Effects 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- 229910052799 carbon Inorganic materials 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 239000001117 sulphuric acid Substances 0.000 description 10
- 235000011149 sulphuric acid Nutrition 0.000 description 10
- 238000000855 fermentation Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 239000003242 anti bacterial agent Substances 0.000 description 8
- 229940088710 antibiotic agent Drugs 0.000 description 8
- 238000010992 reflux Methods 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 238000003818 flash chromatography Methods 0.000 description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- CXESTILCPSBCGQ-UHFFFAOYSA-N 3-amino-5-hydroxybenzoic acid;hydrochloride Chemical compound Cl.NC1=CC(O)=CC(C(O)=O)=C1 CXESTILCPSBCGQ-UHFFFAOYSA-N 0.000 description 5
- CUNFATZHBOZOTB-UHFFFAOYSA-N 3-hydroxy-5-(methylamino)benzoic acid Chemical compound CNC1=CC(O)=CC(C(O)=O)=C1 CUNFATZHBOZOTB-UHFFFAOYSA-N 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- RNVFYQUEEMZKLR-UHFFFAOYSA-N methyl 3,5-dihydroxybenzoate Chemical compound COC(=O)C1=CC(O)=CC(O)=C1 RNVFYQUEEMZKLR-UHFFFAOYSA-N 0.000 description 4
- ATEBXHFBFRCZMA-VXTBVIBXSA-N rifabutin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC(=C2N3)C(=O)C=4C(O)=C5C)C)OC)C5=C1C=4C2=NC13CCN(CC(C)C)CC1 ATEBXHFBFRCZMA-VXTBVIBXSA-N 0.000 description 4
- 229960000885 rifabutin Drugs 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 3
- 229910000831 Steel Inorganic materials 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- WBKFWQBXFREOFH-UHFFFAOYSA-N dichloromethane;ethyl acetate Chemical compound ClCCl.CCOC(C)=O WBKFWQBXFREOFH-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- DMNGQQIFOZYIRA-UHFFFAOYSA-N methyl 3-amino-5-hydroxybenzoate Chemical compound COC(=O)C1=CC(N)=CC(O)=C1 DMNGQQIFOZYIRA-UHFFFAOYSA-N 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- 238000000859 sublimation Methods 0.000 description 3
- 230000008022 sublimation Effects 0.000 description 3
- ANMNOARWGQLKAB-UHFFFAOYSA-N 3-hydroxy-5-(methylamino)benzoic acid;hydrochloride Chemical compound Cl.CNC1=CC(O)=CC(C(O)=O)=C1 ANMNOARWGQLKAB-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- UFBZJXLIYILEID-UHFFFAOYSA-N methyl 3-(dimethylamino)-5-hydroxybenzoate Chemical compound COC(=O)C1=CC(O)=CC(N(C)C)=C1 UFBZJXLIYILEID-UHFFFAOYSA-N 0.000 description 2
- HVPWFAWUNLLRBG-UHFFFAOYSA-N methyl 3-(ethylamino)-5-hydroxybenzoate Chemical compound CCNC1=CC(O)=CC(C(=O)OC)=C1 HVPWFAWUNLLRBG-UHFFFAOYSA-N 0.000 description 2
- PXKDKRMXHVKOAF-UHFFFAOYSA-N methyl 3-hydroxy-5-(methylamino)benzoate Chemical compound CNC1=CC(O)=CC(C(=O)OC)=C1 PXKDKRMXHVKOAF-UHFFFAOYSA-N 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- KKTUQAYCCLMNOA-UHFFFAOYSA-N 2,3-diaminobenzoic acid Chemical compound NC1=CC=CC(C(O)=O)=C1N KKTUQAYCCLMNOA-UHFFFAOYSA-N 0.000 description 1
- HYNQTSZBTIOFKH-UHFFFAOYSA-N 2-Amino-5-hydroxybenzoic acid Chemical compound NC1=CC=C(O)C=C1C(O)=O HYNQTSZBTIOFKH-UHFFFAOYSA-N 0.000 description 1
- BLFPTTBYQKXXIW-UHFFFAOYSA-N 2-amino-3-hydroxy-5-methylbenzoic acid Chemical compound CC1=CC(O)=C(N)C(C(O)=O)=C1 BLFPTTBYQKXXIW-UHFFFAOYSA-N 0.000 description 1
- VYWYYJYRVSBHJQ-UHFFFAOYSA-N 3,5-dinitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 VYWYYJYRVSBHJQ-UHFFFAOYSA-N 0.000 description 1
- UOGXLMFGHYQLQQ-UHFFFAOYSA-N 3-(dimethylamino)-5-hydroxybenzoic acid Chemical compound CN(C)C1=CC(O)=CC(C(O)=O)=C1 UOGXLMFGHYQLQQ-UHFFFAOYSA-N 0.000 description 1
- QCESOQYTNNRNNY-UHFFFAOYSA-N 4-bromo-3,5-difluorobenzenesulfonyl chloride Chemical compound FC1=CC(S(Cl)(=O)=O)=CC(F)=C1Br QCESOQYTNNRNNY-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- STECJAGHUSJQJN-USLFZFAMSA-N LSM-4015 Chemical compound C1([C@@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-USLFZFAMSA-N 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- HRHKSTOGXBBQCB-UHFFFAOYSA-N Mitomycin E Natural products O=C1C(N)=C(C)C(=O)C2=C1C(COC(N)=O)C1(OC)C3N(C)C3CN12 HRHKSTOGXBBQCB-UHFFFAOYSA-N 0.000 description 1
- BTVYFIMKUHNOBZ-ODRIEIDWSA-N Rifamycin S Chemical compound O=C1C(C(O)=C2C)=C3C(=O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O BTVYFIMKUHNOBZ-ODRIEIDWSA-N 0.000 description 1
- BTVYFIMKUHNOBZ-ZDHWWVNNSA-N Rifamycin S Natural products COC1C=COC2(C)Oc3c(C)c(O)c4C(=O)C(=CC(=O)c4c3C2=O)NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C BTVYFIMKUHNOBZ-ZDHWWVNNSA-N 0.000 description 1
- VVJDHJZQBGWPEQ-NXBJUTJHSA-N [(4e,6r,7s,8s,10e,12e,14e,16r)-6,22,24-trihydroxy-16-methoxy-5,7-dimethyl-18-oxo-19-azabicyclo[18.3.1]tetracosa-1(23),4,10,12,14,20(24),21-heptaen-8-yl] (2r)-2-(cyclohexanecarbonylamino)propanoate Chemical compound N([C@H](C)C(=O)O[C@@H]1[C@@H](C)[C@@H](O)/C(C)=C/CCC=2C=C(O)C=C(C=2O)NC(=O)C[C@H](/C=C/C=C/C=C/C1)OC)C(=O)C1CCCCC1 VVJDHJZQBGWPEQ-NXBJUTJHSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- VMGZUMXAOXKLLT-PNBNQRKOSA-N actamycin Chemical compound O=C1\C(C)=C/C(C)C(O)C(C)\C=C/C(O)C\C=C(C)/C(=O)CC(O)C(C)\C=C/C=C\C=C/C(=O)NC2=C(O)C3=CC(C)=C(O)C1=C3C(=O)C2=O VMGZUMXAOXKLLT-PNBNQRKOSA-N 0.000 description 1
- ODRXJBTZWPWLEA-RRDJYBMYSA-N actamycin Natural products CC1C=CC=C/C=C/C(=O)NC2=C(O)C(=O)c3c(cc(C)c(O)c3C(=O)C(=CC(C)C(O)C(C)C=CC(O)CC=C(/C)C(=O)CC1O)C)C2=O ODRXJBTZWPWLEA-RRDJYBMYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- RGFRUPDYJJSLHS-UHFFFAOYSA-N chloroform;methyl acetate Chemical compound ClC(Cl)Cl.COC(C)=O RGFRUPDYJJSLHS-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003041 laboratory chemical Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- QQZUJWCQIDPGJO-UHFFFAOYSA-N methyl 3,5-bis(ethylamino)benzoate Chemical compound CCNC1=CC(NCC)=CC(C(=O)OC)=C1 QQZUJWCQIDPGJO-UHFFFAOYSA-N 0.000 description 1
- KVBVAFAGNOGWPJ-UHFFFAOYSA-N methyl 3,5-bis(methylamino)benzoate Chemical compound CNC1=CC(NC)=CC(C(=O)OC)=C1 KVBVAFAGNOGWPJ-UHFFFAOYSA-N 0.000 description 1
- HRHKSTOGXBBQCB-VFWICMBZSA-N methylmitomycin Chemical compound O=C1C(N)=C(C)C(=O)C2=C1[C@@H](COC(N)=O)[C@@]1(OC)[C@H]3N(C)[C@H]3CN12 HRHKSTOGXBBQCB-VFWICMBZSA-N 0.000 description 1
- 239000013586 microbial product Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229930190950 mycotrienin Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229950004406 porfiromycin Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000000814 tuberculostatic agent Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
TITLE :
PROCESS FOR THE PREPARATION OF 3-A INO-5-HYDROXYBENZOIC ACIDS AND DERIVATIVES AND ANALOGUES THEREOF
TECHNICAL FIELD
This invention relates to a process for the preparation of 3-amino-5-hydroxybenzoic acids and derivatives and analogues thereof. These compounds are of use in the production of antibiotics by fermentation.
BACKGROUND ART
3-Amino-5-hydroxybenzoic acid (1) is a naturally occurring amino acid [J J Kibby and R W Rickards, J. Antibiot., 34, 605 (1981)] which functions as a key intermediate in the formation of certain metabolic products of living systems.
CO.-H
(1) In particular, the amino acid (1) has been proved to be an intermediate in the biological synthesis by microorganisms of several important groups of antibiotics, such as antibiotics of the ansamycin [J J Kibby, I A McDonald, and R W Rickards, J. Chem. Soc, Chem. Commun. 768 (1980); 0 Ghisalba and J Niiesch,
J. Antibiot 34, 64 (1981 K L Rinehart, Jr
M Potgieter, W-Z Jin, C J Pearce, D A Wright, J L C Wright, J A Walter and A G Mclnnes, in Trends in
Antibiotic Research. Genetics, Biosyntheses, Actions and
__
New Substances. Ed., H Umezawa, A L Demain, T Hata and C R Hutchinson, pp. 171-184, Japan Antibiotics Research Association, Tokyo, 1982], maytansinoid [K Hatano, S Akiyama, M Asai and R W Rickards, J. Antibiot. , 35, 1415 (1982)] and mitomycin groups [M G Anderson, J J Kibby, R W Rickards and J M Rothschild, J. Chem. Soc, Chem. Commun., 1277 (1980)]. It may also be involved in the biosynthesis of other types of antibiotic [J J Kibby, I A McDonald and R W Rickards, J. Chem. Soc, Chem. Commun., 768 (1980)], for example, the asukamycin-manumycin type [K Kakinuma, N Ikekawa, A Nakagawa and S Omura, J. Am. Chem. Soc. , 101, 3402 (1979); K Schroder and A Zeeck, Tetrahedron Lett., 4995 (1973); L Slechta, J I Cialdella, S A Mizsak and H Hoeksema, J. Antibiot., 35, 556 (1982)].
These groups of antibiotics include several clinically important representatives, such as the antitubercular agent rifampicin (which is a synthetic modification of the natural ansamycin antibiotic rifamycin S [K L Rinehart, Jr., and L S Shield, Fortschr. Chem. Org. Naturst., 33, 231 (1976)]) and the antitumor agent mitomycin C [R W Franck, Fortschr. Chem. Org. Naturst., 3_8_, 1 (1979)].
The molecular complexity of antibiotics of all these types is such that their synthesis by laboratory chemical processes can only provide small amounts of material. The significant quantities required for clinical use and continued laboratory studies can, at present, only be produced by fermentation of the appropriate microorganism. Such fermentations are carried out under controlled conditions using a variety of nutrient media which permit growth and antibiotic production. A disadvantage of these fermentation procedures is that environmental conditions which would favour the production of the antibiotic do not necessarily favour the production of its precursor 3-
OMPI
amino-5-hydroxybenzoic acid. In some fermentations th production of 3-amino-5-hydroxybenzoic acid may b limited, either nutritionally or genetically, to th extent that the full potential of the particula microorganism for antibiotic production may not b realised. In these circumstances, the addition o exogenous 3-amino-5-hydroxybenzoic acid to the mediu may increase the resultant antibiotic yield. Fo example, supplementation of laboratory fermentatio media with the amino acid (1) has been shown by two o the present inventors to increase two to four fold th production of the mitomycin antibiotic porfiromycin an of the ansamycin antibiotics actamycin [A M Becker A J Herlt, G L Hilton, J J Kibby and R W Rickards J Antibiot. , submitted for publication] and mycotrienin Also, the production of the ansamycin antibioti rifa ycin B by a genetically impaired mutant wa restored to the level of the parent strain by th addition of 3-amino-5-hydroxybenzoic acid to th fermentation [0 Ghisalba and J Nϋesch, J. Antibiot., 3_4, 64 (1981)].
Further, 3-alkylamino-5-hydroxybenzoic acids, when added to the appropriate fermentation media, may give rise to the production of the corresponding N-alkylated homologues of the antibiotic normally produced from 3- amino-5-hydroxybenzoic acid itself. For example, 3- hydroxy-5-methylaminobenzoic acid, added to the fermentation media, may result in the increased production of antibiotics such as the maytansinoids [K L Rinehart, Jr., and L S Shield, Fortschr. Chem. Org. Naturst., 33, 231 (1976)], which themselves carry an N-methyl group derived biogenetically from the amino group of the acid (1).
Such stimulation of production when applied to a commercial rather than laboratory scale would necessitate access to large quantities of 3-amino-5-
OMPΓ -
hydroxybenzoic acid and its N-alkyl analogues. Although 3-amino-5-hydroxybenzoic acid is a natural microbial product, this amino acid has been detected only in trace quantities in one microorganism [J J Kibby and R W Rickards, J. Antibiot., 34, 605 (1981)]. There are two syntheses of 3-amino-5-hydroxybenzoic acid published in the chemical literature [H Bickel, P Mertens, V Prelog, J Seibl and A Walser, Tetrahedron, Suppl. 8, 171 (1966), subsequently modified by 0 Ghisalba and J Nϋesch, J. Antibiot., 34, 64 (1981); and A J Herlt, J J Kibby and R W Rickards, Aust. J. Chem. , 34, 1319 (1981)], both starting from the relatively expensive 3, 5-dinitrobenzoic acid. The former synthesis requires a lengthy sequence of reaction steps while the latter, although short, employs potentially toxic chemicals, the use of which would be undesirable on a large scale.
DISCLOSURE OF THE INVENTION
It is an object of the present invention to provide a convenient and direct process for the preparation of 3-amino-5-hydroxybenzoic acids and derivatives and analogues thereof which utilises cheap, non-toxic, readily available reagents, proceeds in high yield without complex purification stages, and is capable of providing commercial quantities of product.
This objective is achieved by the reaction of a
3 ,5-dihydroxybenzoic acid with ammonia, or an amine, which is then followed either by hydrolysis and, when required, esterification, or is followed by direct esterification.
According to the present invention, there is provided a process for the preparation of compounds of the general formula (2):
( 2 )
wherein R 1 represents the radicals -OR2 or -NR3R4; and
R , R , R , R , R and R represent radicals separately selected from hydrogen and alkyl, or the acid addition salts thereof, comprising: a) the reaction of a 3 , 5-dihydroxybenzoic acid of general formula (3):
R-
(3) with a compound of the general formula (4
wherein R , R , R , R and R are as hereinbefore defined, to produce a compound of general formula (2b):
( 2b :
wherein R" R4, R5, R and R are as hereinbefore defined; and, when preparing compounds of general formula (2) wherein R represents the radical -OR further comprising:
b) hydrolysis of the compound of general formula (2b) to produce a carboxylic acid of general formula (2c):
(2c)
wherein R , R4, R5, R and R are as hereinbefore defined; and c) esterification of the acid of general formula (2c) to produce an ester of general formula (2d):
wherein R 2 represents alkyl and R3
R4, R5, R^ and R are as hereinbefore defined;
or, when preparing compounds of general formula { 2 wwhheerreeiinn RR 1 rreepprreesssents the radical -OR 2 and R 2 represents alkyl, comprising:
d) esterification of the amide of general formula (2b) in an acidic medium to produce an ester of general formula (2d) .
As used throughout the specification, the term "alkyl" is used to denote a straight- or branched-chain hydrocarbon radical of 1 to 10 carbon atoms.
The pressure and temperature conditions required for the reaction of a 3 , 5-dihydroxybenzoic acid of the general formula (3) with a compound of the general formula (4) vary with the nature and quantity of reactants used. Generally, however, it has been found that a temperature range of about 100 C to about 300 C and a pressure range of about 15 p.s.i. to 500 p.s.i. have been satisfactory. In particular, a temperature of about 180 C and a pressure of about 320 p.s.i. have resulted in good yields of the required products.
Compounds of general formulae (3) and (4) are either known, or can be prepared from known compounds by standard reactions well known in the art. For example, 3, 5-dihydroxybenzoic acid is commercially available, as is ammonia and a large number of mono- and dialkylamines.
Preferably, the radicals represented by R 2, R3, R4,
" f> 7
R , R and R are separately selected from the group consisting of hydrogen, methyl and ethyl.
More preferably, the radicals represented by R 2, R3,
R , R , R and R are all hydrogen. Thus the reaction of 3, 5-dihydroxybenzoic acid with ammonia, produces the amide (2e) :
( 2e )
Hydrolysis of the amide (2e) produces 3-amino-5- hydroxybenzoic acid (1).
If ammonia is replaced by an amine, mono- or disubstituted with alkyl radicals, such as methylamine, ethylamine, or dimethylamine, the corresponding N- alkylated homologues of 3-amino-5-hydroxybenzoic acid (for example, 3-methylamino-, 3-ethylamino-, or 3- dimethylamino-5-hydroxybenzoic acid) can be prepared.
The preparation of the ester of general formula (2d) can, if desired, provide a means for obtaining pure acid of general formula (2c). The crude reaction mixture containing the amide of general formula (2b) or the acid of general formula (2c) is esterified, by conventional techniques, to produce the ester of general formula (2d) which in some cases may be more readily separated from impurities. The ester of general formula (2d) is then hydrolysed with acid or base. Adjustment of the pH of the hydrolysis solution precipitates the free amino acid of general formula (2c), or its acid addition salt.
Preferably, methanolic sulphuric acid is used to prepare a methyl ester, although other esters can, of course, be employed.
It will be appreciated that, after the reaction of a 3,5-dihydroxybenzoic acid of general formula (3) with a compound of general formula (4), the amide of general
OMPI VΛ --. WIPO
& ?N'AT\0
formula ( 2b ) is not the sole product . Another product is the ammonium salt of a 3-amino-5-hydroxybenzoic acid as represented by the general formula ( 2f ) :
« 3 4®
CO -, NH2R R
wherein R , R , R , R and R are as hereinbefore defined.
It is not necessary to separate the salt of general formula (2f) from the amide of general formula (2b) as treatment of the crude product mixture with acid produces a single carboxylic acid of general formula (2c). Alternatively, esterification of the crude product mixture in an acidic medium produces a single ester of the general formula (2d).
Since many microorganisms used in antibiotic production have efficient esterase enzymes, increased antibiotic production, or the formation of antibiotic analogues as described above, may also be achieved by direct supplementation of fermentation media with esters of 3-amino-5-hydroxybenzoic acid (1) or its analogues (for example, 3-N-alkylamino-5-hydroxybenzoic acids). In this case the esters (2d) which are described above may be used directly without hydrolysis.
DETAILED DESCRIPTION OF EMBODIMENTS
Specific details of the compounds of the present invention and the reactions involved in the processes of this invention are illustrated by the following examples. In these examples, all temperatures are in
degrees Centigrade, and technical terms (e.g. chromatography, etc.,) have the usual meaning in the art. Crude reaction products can be purified by the means described herein, or by other means known in the art.
EXAMPLE 1
3-amino-5-hydroxybenzoic acid hydrochloride: METHOD 1
A mixture of 3, 5-dihydroxybenzoic acid (2g, 13mmol) , ammonium chloride (1.7g, 32mmol) and aqueous ammonia (28%, 6ml) was heated in a steel bomb at 180° for 40 h. After cooling the reaction solution was evaporated to dryness and the residue taken up in 6N aqueous hydrochloric acid (100ml). The solution was kept at reflux for 16 h, filtered and concentrated (ca. 25ml). On cooling 3-amino-5-hydroxybenzoic acid hydrochloride (1.72 g, 70%), pure by H n.m.r., was collected as greyish crystals. Treatment with charcoal and recrystallization from 6N aqueous hydrochloric acid gave the hydrochloride of (1) as white crystals, m.p. 200- 230 (dec), identical by spectroscopic and mixed m.p. comparison with an authentic sample [A J Herlt, J-J Kibby and R W Rickards, Aust. J. Chem, 34_, 1319 (1981)]. Extraction with ethyl acetate of the mother liquor of the original crystallization led to the recovery of starting material (288 mg, 14%).
EXAMPLE 2
3-amino-5-hydroxybenzoic acid hydrochloride: METHOD 2
Methyl 3-amino-5-hydroxybenzoate (200mg, 1.2mmol) prepared as in Example 4 in 6N aqueous hydrochloric acid
(5ml) was heated at reflux for 2 h. The solution on cooling deposited crystalline, analytically pure
3-amino-5-hydroxybenzoic acid hydrochloride (215mg, 95%), identical with an authentic sample [A J Herlt, J J Kibby and R W Rickards, Aust. J. Chem. , 34, 131 (1981)].
EXAMPLE 3
3-amino-5-hydroxybenzoic acid
To 3-amino-5-hydroxybenzoic acid hydrochloride (47mg, 0.25mmol) prepared as in Example 1 or 2 in water (0.8ml) was added 2N aqueous sodium hydroxide until the pH of the solution reached 4. The cooled solution yielded crystalline 3-amino-5-hydroxybenzoic acid (37mg, 96%), identical with an authentic sample [A J Herlt, J J Kibby, and R W Rickards, Aust. J. Chem. , 34, 1319 (1981)].
EXAMPLE 4
methyl 3-amino-5-hydroxybenzoate
3 , 5-Dihydroxybenzoic acid was reacted with ammonium chloride and aqueous ammonia as described under Example 1. The reaction mixture was evaporated to dryness and the residue taken up in methanol (100 ml). Concentrated sulphuric acid (3ml) was added dropwise and the solution kept at reflux temperature for 36 h. After cooling the solution was evaporated, the residue taken up in ice- cold water, and the aqueous solution extracted with ether (x 3). The combined extracts were washed with ice-cold IN aqueous sulphuric acid (x 2), then with brine. Drying (MgSO.) and evaporation of the ether gave the methyl ester of starting material (220mg, 10%) containing a small amount of methyl 3-( 3 ' -carbomethoxy-
5'-hydroxyphenylamino)-5-hydroxybenzoate (70mg, 2%),
H n.m.r. (dg-acetone) 68.5, 7.6, OH, NH; 7.27, 7.03,
6.88, 3 ArH; 3.81, COOCH 1,-3 .• m Ul//z <---. 317.0891 (M+, calc. for
C , ,H, cNO , : 317 , 16 15 6 0893 )
- tJRlT
OMPI
^ IPO ■
The aqueous solution and aqueous sulphuric acid washings were combined, adjusted to pH 7 with solid sodium bicarbonate and extracted with ethyl acetate (x 4). The extracts were washed with brine, dried 5 (MgSO.) and evaporated. Flash chromatography on silica with ethyl acetate-dichloromethane (2:3) as eluant or recrystallization from methyl acetate-chloroform to remove methyl 3,5-diaminobenzoate gave methyl 3-amino- 5-hydroxybenzoate (1.63g, 75%), m.p. 125-127 (Found: C,
10 57.5; H, 5.42; N, 8.18. CgHgNO.- requires C, 57.5; H, 5.43; N, 8.38%). ~E n.m.r. (dg-acetone) δ8.16, bs, OH; 6.88, m, C(2)-H; 6.80, m, C(6)-H; 6.42, m, C(4)-H; 4.73, bs, NH-; 3.80, s, COOCH-, . C n.m.r. (dg-acetone) ppm 167.71, s, COOCH3; 158.99, s, C(5); 150.66, s, C { 3 ) ;
15 132.68, s, C(l); 108.12, d, J = 161 Hz, and 105.82, d, J = 164 Hz, C(2) and C(6); 106.43, d, J = 156 Hz, C(4); 52.05, q, J = 147 Hz, COOCH-.. m/z 167 (M+, 100%), 136 (M+-OMe, 55), 109 (35), 108 (35). From flash chromatography there was also isolated methyl 3,5-
20 diaminobenzoate (162mg, 7%), m.p. 123-126 after sublimation. H n.m.r. (d,-acetone) 56.62, d, J = 2.5 Hz, C(2)-H and C(6)-H; 6.19, t, J = 2.5 Hz, C(4)-H; 4.42, bs, NH2 ; 3.75, s, COOCH-.. m/z 167 (M+ + H, 48%), 166 (M+, 100), 136(12), 135 (M+ -OMe, 27),
25 109(26), 108(67), 107(43).
EXAMPLE 5
3-hydroxy-5-methylaminobenzoic acid: METHOD 1
30
3,5-Dihydroxybenzoic acid (2g, 13mmol) was added under vigorous stirring to a solution of sodium carbonate (1.033g, 9.75mmol) in water (5ml). Stirring was continued until no further carbon dioxide evolved
35 (4 h). After addition of 40% aqueous methylamine (5ml) under ice-cooling, the mixture was heated in a steel bomb at 180 for 16 h. The cooled reaction solution was evaporated to dryness, the residue taken up in 6N
OMPI
aqueous hydrochloric acid (100ml), and the solutio heated at reflux temperature for 36 h. After cooling, the acidic solution was extracted with ethyl acetate The combined organic phases were washed with cold I aqueous hydrochloric acid, then with brine. Dryin (MgSO.) and evaporation of the organic solvent gav starting material (962 mg, 48%). The combined aqueou solutions were adjusted to pH 4-5 with solid sodiu bicarbonate, saturated with sodium chloride an extracted with ethyl acetate. Evaporation of the drie extracts gave 3-hydroxy-5-methylaminobenzoic aci (1.052g, 48%), m.p. 205-208° (dec.) after recrystallization from ethyl acetate-hexane (Found: C, 57.6; H, 5.48; N, 8.13. CQHQNO-. requires C, 57.5; H, 5.43; N, 8.38%). 1H n.m.r. (d4~methanol) 66.82, m, C(2)-H and C(6)-H; 6.29, t, J = 2 Hz, C(4)-H; 2.75, s, NHCH3. m/z 167 (M+,100%), 166(85), 122 (M+- C00H, 12).
EXAMPLE 6
3-hydroxy-5-methylaminobenzoic acid: METHOD 2
Reaction of 3, 5-dihydroxybenzoic acid and sodium carbonate in aqueous methylamine, and subsequent hydrolysis with hydrochloric acid was carried out as described under Example 5. After removal of the aqueous solvent under vacuum, the residue was taken up in methanol (100ml). Concentrated sulphuric acid (3ml) was added dropwise and the solution kept at reflux for 16 h. The residue remaining on evaporation of the solvent was worked-up as described for Example 1, yielding methyl 3 , 5-dihydroxybenzoate (633mg, 29%) from the acidic fraction, and from the neutral fraction after flash chromatography methyl 3-hydroxy-5-methylaminobenzoate (1.32g, 56%), m.p. 51-53° from chloroform (Found: C, 59.5; H, 6.27; N, 7.49. CgH-^NO.. requires C, 59.7; H, 6.12; N, 7.73%). 1H n.m.r. (d6~acetone) 58.18, bs, OH;
OMPI ^y
6.78, d, J = 2 Hz, C(2)-H and C(6)-H; 6.31, t, J = 2 Hz, C(4)-H; 5.06, bs, NH; 3.80, s, COOCH3; 2.78, d, J = 5 Hz, NHCH3. m/z_ 181 (M+, 100%), 180(19), 150 (M+- OMe, 28), 123(41), 122(43).
Methyl 3-hydroxy-5-methylaminobenzoate (500mg, 2.76mmol) in 6N aqueous hydrochloric acid (4ml) was heated at reflux for 14 h. After cooling the crystals were filtered and dried to give 3-hydroxy-5- methylaminobenzoic acid hydrochloride (512mg, 91%), m.p. 190-193° (dec). XH n.m.r. (d4~methanol) 57.58, m, C(2)-H and C(6)-H; 7.19, m, C(4)-H; 3.07, s, NH-CH... m/z 167 (M+, 100%), 166(93), 122 (M+-COOH, 12).
To 3-hydroxy-5-methylaminobenzoic acid hydrochloride (500mg, 2.46mmol) in water (7ml) was added 2N aqueous sodium hydroxide until the pH of the solution reached 4. Saturation with sodium chloride and extraction with ethyl acetate gave 3-hydroxy-5-methylaminobenzoic acid (363mg, 88%) identical with the material described in Example 5.
EXAMPLE 7
3-hydroxy-5-methylaminobenzoic acid: METHOD 3
Reaction of 3, 5-dihydroxybenzoic acid and sodium carbonate with aqueous methylamine, subsequent hydrolysis with hydrochloric acid, esterification with methanol and sulphuric acid and the first stages of work-up were carried out as described under Example 6. The ether extracts from the neutralized aqueous solution, however, were not evaporated but extracted with cold 2N aqueous sodium hydroxide (x 2), washed with brine, dried (Na_SO. ) and evaporated to give crystalline methyl 3,5-di(methylamino)benzoate (254mg, 10%), m.p. 79-82° after sublimation (Found: C, 61.7; H, 7.32; N, 14.2. cιoH 14 N2°2 requires C, 61.8; H, 7.27; N, 14.4%).
"^H n.m.r. (d,-acetone) 56.58, d, J = 2 Hz, C(2) -H an
D
C(6)-H; 6.05, t, J = 2 Hz, C(4)-H; 4.82, bs, NH; 3.77, s, COOCH3; 2.75, d, J = 5 Hz, NHCH3. m z 194 (M+, 100%), 193(10), 163 (M+-OMe, 8), 136(33), 135(25) .
The aqueous sodium hydroxide extracts were the acidified to pH 6 under ice-cooling with concentrate phosphoric acid, saturated with sodium chloride, an extracted with ethyl acetate (x 4) . Drying (Na-SO.) and evaporation of the solvent gave 3-hydroxy-5-methyl- aminobenzoic acid (1.17g, 54%), identical with the material described in Example 5.
EXAMPLE 8
methyl 3-ethylamino-5-hydroxybenzoate
3 , 5-Dihydroxybenzoic acid (2.0g, 13mmol) and sodium carbonate (1.033g, 9.75mmol) in water (6ml) were reacted with ethylamine (5.1ml, 78mmol) following a similar procedure to that described in Example 5. Hydrolysis with hydrochloric acid, esterification with methanol and sulphuric acid followed by work-up gave methyl 3,5- dihydroxybenzoate (1.05g, 48%) which could be recycled after hydrolysis, and, after flash chromatography with ethyl acetate-dichloromethane (1:6), methyl 3,5- di (ethylamino)benzoate (57mg, 2%), m.p. 79-80° from chloroform-hexane (Found: C, 64.7; H, 8.30; N, 12.5.
C12H18N2°2 recϊuires c' 64.8; H, 8.16; N, 12.6%). H n.m.r. (dg-acetone) 56.59, d, J = 2.5 Hz, C( 2 ) -H and C(6)-H; 6.11, t, J = 2.5 Hz, C(4)-H; 4.70, bs, NH; 3.79, s, COOCH3; 3.15, bq, J = 7 Hz, NHCH_2CH3 ; 1.22, t, J = 7 Hz, CH2CH3. m/z 222 (M+, 67%), 207 (M+-CH3, 100), 191 (M -OMe, 10), 164(6), 163(6). The main product from flash chromatography was methyl 3-ethylamino-5-hydroxy- benzoate (940mg, 37%), m.p. 107-108° from chloroform (Found: C, 61.2; H, 6.82; N, 7.00. cιoHτ.3N03 requires C, 61.5; H, 6.71; N, 7.18%). 1H n.m.r. (dg-acetone)
OMPI ? WIPO
68.14, s, OH; 6.80, m, C(2)-H and C(6)-H; 6.34, t, J = 2.5 Hz, C(4)-H; 4.95, bs, NH; 3.81, s, COOCH3 ; 3.15, d x q, J = 5 Hz and J = 7 Hz, NHCH2CH3 ; 1.24, t, J = 7Hz, CH2CH3. m/z_ 196 (M+ + H, 15%), 195 (M+, 75), 5 180 (M+-CH3, 100), 164 (M+-OMe, 12), 136(10).
EXAMPLE 9
methyl 3-dimethylamino-5-hydroxybenzoate 0
A mixture of 3, 5-dihydroxybenzoic acid (2.0 g, 13 mmol), dimethylammonium chloride (2.65 g, 32.5 mmol) and aqueous dimethylamine (20%, 6 ml) was heated in a steel bomb at 180° for 40 h. After cooling the reaction 5 solution was evaporated to dryness and the residue taken up in methanol (100 ml). Concentrated sulphuric acid (3 ml) was added dropwise and the solution kept at reflux for 24 h. After cooling the solution was evaporated, the residue taken up in ice-cold water, and 0 the aqueous solution extracted with ether (x 3). The combined extracts were washed with ice-cold IN aqueous sulphuric acid (x 2), then with brine. Drying (MgSO.) and evaporation of the ether gave the methyl ester of starting material (1.3 g, 60%). 5
The aqueous solution and aqueous sulphuric acid washings were combined, adjusted to pH 7 with solid sodium bicarbonate and extracted with ether (x 3). The extracts were washed with brine, dried (MgSO.) and 0 evaporated. Flash chromatography on silica with ethyl acetate-dichloromethane (1:9) as eluant gave methyl 3-dimethylamino-5-hydroxybenzoate (510 mg, 20%), m.p. 126-129° after sublimation (Found: C, 61.8; H, 6.67; N, 6.84. C10H13NO3 requires C, 61.5; H, 6.71; N, 7.18%). 5 H n.m.r. (d,-acetone) 58.26, s, OH; 6.90, m, and 6.83, m, C(2)-H and C(6)-H; 6.42, t, C(4)-H; 3.80, s, COOCH3; 2.91, s, N(CH3)2. m/z 195 (M+, 100%), 194 (M+-H, 69), 164 (M+-OMe, 12), 137 (M+-C2H202, 7).136 (M+-C02Me, 15).
It will, of course, be appreciated that the abov examples are given by way of exemplification of th invention only, and that changes may be made to th details set out therein without departing from the scop of the invention.
Claims (1)
- \ S1. A process for the preparation of compounds of the general formula (2):COR"wherein R 1 represents the radicals -OR2 or-NR3R4; and R2, R3, R , R5, R6 and R7 represent radicals separately selected from hydrogen and alkyl, or the acid addition salts thereof, comprising:a) the reaction of a 3, 5-dihydroxybenzoic acid of general formula (3):with a compound of the general formula (4):wherein R 3, R4, R5, R and R are as hereinbefore defined, to produce a compound of general formula (2b):OMPI 3 4 CONR R( 2b )wherein R 3 , R 4 , R" c R6 and R7 are as hereinbefore defined ;and, when preparing compounds of general formula(2) wherein R 1 represents the radical -OR2, further comprising:b) hydrolysis of the compound of general formula (2b) to produce a carboxylic acid of general formula (2c) :wherein R , R , R , R and are as hereinbefore defined; andc) esterification of the acid of general formula (2c) to produce an ester of general formula (2d):(2d)wherein R 2 represents alkyl and R3 , R4, R"R6 and R7 are as hereinbefore defined;or, when preparing compounds of general formula (2)1 2 2 wherein R represents the radical -OR and R represents alkyl, comprising:d) esterification of the amide of general formula (2b) in an acidic medium to produce an ester of general formula (2d).2. A process as defined in claim 1 wherein the reaction of a 3, 5-hydroxybenzoic acid of general formula (3) with a compound of general formula (4) is carried out under pressure.3. A process as defined in claim 2 wherein the pressure ranges from about 15 p.s.i. to 500 p.s.i.4. A process as defined in claim 3 wherein the pressure is about 320 p.s.i.5. A process as defined in any one of claims 1 to 4 wherein R,2", R„3" , „R4R5, R and R are separately selected from the group consisting of hydrogen, methyl and ethyl.A process as defined in claim 5 wherein R 2, R3, R4,5 6 7 R , R and R all represent hydrogen.OMPI IPO 7. Compounds of the general formula (2) as defined i claim 1, whenever prepared by a process as define in any one of claims 1 to 6.8. A process as defined in claim 1 as hereinbefor described with reference to the Examples.9. Compounds of the general formula (2) as defined i claim 1, whenever prepared by a process as define in claim 1, as hereinbefore described wit reference to the Examples.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPF5512 | 1982-08-23 | ||
| PCT/AU1983/000111 WO1984000750A1 (en) | 1982-08-23 | 1983-08-22 | Process for the preparation of 3-amino-5-hydroxybenzoic acids and derivatives and analogues thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1885083A true AU1885083A (en) | 1984-03-07 |
Family
ID=3761177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18850/83A Abandoned AU1885083A (en) | 1982-08-23 | 1983-08-22 | Process for the preparation of 3-amino-5-hydroxybenzoic acidsand derivatives and analogues thereof |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU1885083A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU586257B2 (en) * | 1985-06-26 | 1989-07-06 | Dow Chemical Company, The | Preparation of 3-amino-4-hydroxybenzoic acids |
-
1983
- 1983-08-22 AU AU18850/83A patent/AU1885083A/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU586257B2 (en) * | 1985-06-26 | 1989-07-06 | Dow Chemical Company, The | Preparation of 3-amino-4-hydroxybenzoic acids |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4331803A (en) | Novel erythromycin compounds | |
| FI91263C (en) | Process for the preparation of azithromycin dihydrate | |
| US4224239A (en) | Process for preparing optically active amino acid or mandelic acid | |
| JP2941350B2 (en) | Process for producing R (+)-aminocarnitine and S (-)-aminocarnitine | |
| WO1984000750A1 (en) | Process for the preparation of 3-amino-5-hydroxybenzoic acids and derivatives and analogues thereof | |
| HK1005866B (en) | Process for the production of r(+)-aminocarnitine and s(-)-amino-carnitine | |
| AU1885083A (en) | Process for the preparation of 3-amino-5-hydroxybenzoic acidsand derivatives and analogues thereof | |
| JPS6366200B2 (en) | ||
| EP0320000B1 (en) | Hydroxamic acid derivatives | |
| JPH06311888A (en) | Improved production method for l-(-)- carnitine from waste of opposite configuration | |
| US5041637A (en) | Process for the synthesis of optically active aminoacids | |
| Becker et al. | An expedient synthesis of 3-amino-5-hydroxy-benzoic acid and its N-alkyl analogues | |
| JP3635102B2 (en) | Improved process for producing L-(-)-carnitine from wastes of opposite configuration | |
| EP0129163B1 (en) | Arphamenine and its related compounds, a process for their preparation and their use as medicaments | |
| EP0222561A2 (en) | Process for enzymatic separation of optical isomers of 2-aminobutanol | |
| SK279571B6 (en) | Process and intermediate for the purification of oxytetracycline | |
| US4535177A (en) | N-substituted amino acid derivatives | |
| CN86108424A (en) | The synthetic method of nizatidine | |
| KR102583743B1 (en) | Method for each individual synthesis of l, d-erdosteine | |
| US4939241A (en) | Amino acid derivatives of antitumor activity | |
| SU1274626A3 (en) | Method of producing n-methyl-11-aza-10-deoxo-10-dihydroerythromycin a | |
| JPS58876B2 (en) | FR-1923 Bushitsuno Seizouhouhou | |
| US5081289A (en) | Synthesis and isolation of nopaline and its analogues | |
| JP2971204B2 (en) | New substance WK-2955 and method for producing the same | |
| JP3030896B2 (en) | WB968 substance group and production method thereof |